These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8681448)

  • 21. TP53 polymorphisms and haplotypes in South Amerindians and neo-Brazilians.
    Gaspar PA; Hutz MH; Salzano FM; Weimer TA
    Ann Hum Biol; 2001; 28(2):184-94. PubMed ID: 11293726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients.
    Khaliq S; Hameed A; Khaliq T; Ayub Q; Qamar R; Mohyuddin A; Mazhar K; Qasim-Mehdi S
    Genet Test; 2000; 4(1):23-9. PubMed ID: 10794357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population.
    Ozbey U; Yüce H; Namli M; Elkiran T
    Genet Res Int; 2011; 2011():483851. PubMed ID: 22567355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
    Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
    Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 single nucleotide polymorphisms and bladder cancer.
    Biroš E; Kalina I; Salagovic J; Habalová V; Hriv ák M; Valanský L
    Neoplasma; 2000; 47(5):303-6. PubMed ID: 11130248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population.
    Habyarimana T; Attaleb M; Mugenzi P; Mazarati JB; Bakri Y; El Mzibri M
    Pathobiology; 2018; 85(3):186-191. PubMed ID: 29131100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
    Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
    Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of p53 and CDKN1A genotypes with endometriosis.
    Ying TH; Tseng CJ; Tsai SJ; Hsieh SC; Lee HZ; Hsieh YH; Bau DT
    Anticancer Res; 2011 Dec; 31(12):4301-6. PubMed ID: 22199295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma.
    Golovleva I; Birgander R; Själander A; Lundgren E; Beckman L
    Carcinogenesis; 1997 Apr; 18(4):645-7. PubMed ID: 9111194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
    Surekha D; Sailaja K; Rao DN; Padma T; Raghunadharao D; Vishnupriya S
    Asian Pac J Cancer Prev; 2011; 12(8):1893-8. PubMed ID: 22292621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
    Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
    Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 polymorphisms in Russia and Belarus: correlation of the 2-1-1 haplotype frequency with longitude.
    Khrunin AV; Tarskaia LA; Spitsyn VA; Lylova OI; Bebyakova NA; Mikulich AI; Limborska SA
    Mol Genet Genomics; 2005 Feb; 272(6):666-72. PubMed ID: 15654624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
    Jin Q; Hemminki K; Grzybowska E; Klaes R; Söderberg M; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Pamula J; Pekala W; Försti A
    Int J Cancer; 2004 Oct; 112(1):94-9. PubMed ID: 15305380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome.
    Morten BC; Wong-Brown MW; Scott RJ; Avery-Kiejda KA
    Carcinogenesis; 2016 Jan; 37(1):81-86. PubMed ID: 26586794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.
    Trifa F; Karray-Chouayekh S; Mabrouk I; Baccouche S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Cancer Epidemiol; 2010 Apr; 34(2):184-8. PubMed ID: 20233677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
    Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
    Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.